Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial

Background: Limited success of previous clinical trials for Fragile X syndrome (FXS) has led researchers to consider combining different drugs to correct the pleiotropic consequences caused by the absence of the Fragile X mental retardation protein (FMRP). Here, we report the results of the LovaMiX...

Descripción completa

Detalles Bibliográficos
Autores principales: Champigny, Camille, Morin-Parent, Florence, Bellehumeur-Lefebvre, Laurence, Çaku, Artuela, Lepage, Jean-François, Corbin, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763805/
https://www.ncbi.nlm.nih.gov/pubmed/35058813
http://dx.doi.org/10.3389/fpsyt.2021.762967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763805/
https://www.ncbi.nlm.nih.gov/pubmed/35058813
http://dx.doi.org/10.3389/fpsyt.2021.762967

Ejemplares similares